Top Markets
Coin of the day
Wuhan YZY Biopharma Co Ltd Wuhan YZY Biopharma Co Ltd

Wuhan YZY Biopharma Co Ltd

2496
株式のランク #22213
Wuhan YZY Biopharma Co., Ltd. is a biotechnology enterprise specializing in the... Wuhan YZY Biopharma Co., Ltd. is a biotechnology enterprise specializing in the development of bispecific antibody-based treatments. Its therapeutic focus areas include various cancers, their associated complications, and age-related ophthalmic conditions. The company's extensive portfolio of drug candidates aims to address a wide range of diseases, such as malignant ascites, malignant pleural effusion, various solid tumors (including pancreatic cancer, hepatocellular carcinoma, other advanced solid tumors, and HER2-positive solid tumors), small cell lung cancer, and relapsed/refractory multiple myeloma. Additionally, they are advancing therapies for COVID-19 and several eye disorders like wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and other conditions characterized by abnormal blood vessel formation in the eye. The company, established in 2010, is headquartered in Wuhan, China.
株価
$0.46053443
最終同期: 2026-08-13
時価総額
$92.44M
変化(1日)
0.00%
変化(1年)
-36.86%
CN
取引 Wuhan YZY Biopharma Co Ltd (2496)

カテゴリー

Wuhan YZY Biopharma Co Ltd(2496)の株式分割履歴
Wuhan YZY Biopharma Co Ltd株(シンボル:2496)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 23, 2026に行われました。
Aug 23, 2026より前に購入された2496株は、現在02496株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH